Research Topics
Genomes and Genes | A N HoughtonSummaryAffiliation: Memorial Sloan-Kettering Cancer Center Country: USA Publications
Research Grants
| Collaborators
|
Detail Information
Publications
Immunity against cancer: lessons learned from melanomaA N Houghton
Memorial Sloan Kettering Cancer Center and Weill Medical School of Cornell University, 1275 York Avenue, New York, NY 10021, USA
Curr Opin Immunol 13:134-40. 2001..The view of what the immune system can see is extending to mutations and parts of the genome that are normally invisible...
Antigens recognized by autologous antibodies of patients with soft tissue sarcomaNeil H Segal
Swim Across America Laboratory, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
Cancer Immun 5:4. 2005..Further studies of these selected novel STS antigens are warranted to identify and characterize potential antigen targets expressed by STS...
Focus on melanomaAlan N Houghton
Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA
Cancer Cell 2:275-8. 2002
Identification of cancer-testis genes expressed by melanoma and soft tissue sarcoma using bioinformaticsNeil H Segal
Swim Across America Laboratory, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
Cancer Immun 5:2. 2005....
Immune recognition of self in immunity against cancerAlan N Houghton
The Swim Across America Laboratory of Tumor Immunology, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA
J Clin Invest 114:468-71. 2004
The role of the immune system in early epithelial carcinogenesis: B-ware the double-edged swordAlan N Houghton
Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
Cancer Cell 7:403-5. 2005..These are surprising observations, linking antibodies of the adaptive immune system to innate immune responses that drive epithelial carcinogenesis...
LIGHTing the way for tumor immunityAlan N Houghton
Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA
Nat Immunol 5:123-4. 2004
Tumor endothelial marker 8 enhances tumor immunity in conjunction with immunization against differentiation AgP Felicetti
Swim Across America Laboratory of Tumor Immunology, Memorial Sloan Kettering Cancer Center, New York, USA
Cytotherapy 9:23-34. 2007..Tumor endothelial marker 8 (TEM8) is expressed in the neovasculature of human tumors, and in the mouse melanoma B16, but its expression is limited in normal adult tissues. We describe a DNA vaccine combining xenogeneic tumor Ag and TEM8...
Alternative roles for interferon-gamma in the immune response to DNA vaccines encoding related melanosomal antigensJ D Wolchok
The Swim Across America Laboratory, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
Cancer Immun 1:9. 2001..These results show that immunity to TRP-2 following DNA immunization uses an IFN-gamma-dependent Th1 pathway, but immunity to gp75/TRP-1 is down-regulated by IFN-gamma...
Paucity of functional T-cell memory to melanoma antigens in healthy donors and melanoma patientsM V Dhodapkar
Laboratory of Cellular Physiology and Immunology, The Rockefeller University, New York, New York 10021, USA
Clin Cancer Res 6:4831-8. 2000....
Evaluation of CD8(+) T-cell frequencies by the Elispot assay in healthy individuals and in patients with metastatic melanoma immunized with tyrosinase peptideJ J Lewis
Swim Across America Laboratory, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
Int J Cancer 87:391-8. 2000..1/2,000 in the second patient. These results demonstrate that modest expansion of peptide-specific CD8(+) T cells can be generated in vivo by immunization with peptide plus QS-21 in at least a subset of patients with melanoma...
Cell surface antigens of human melanocytes and melanoma. Expression of adenosine deaminase binding protein is extinguished with melanocyte transformationA N Houghton
Memorial Sloan Kettering Cancer Center, New York 10021
J Exp Med 167:197-212. 1988..These studies demonstrate that ADAbp expression is lost with malignant transformation of melanocytes, presumably at an early stage in the transformation process...
Tumor endothelial marker 8 enhances tumor immunity in conjunction with immnization against differentiation AgP Felicetti
Swim Across America Laboratory of Tumor Immunology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
Cytotherapy 9:23-34. 2007..Tumor endothelial marker 8 (TEM8) is expressed in the neovasculature of human tumors, and in the mouse melanoma B16, but its expression is limited in normal adult tissues. We describe a DNA vaccine combining xenogeneic tumor Ag and TEM8...
Insect cells as HLA-restricted antigen-presenting cells for the IFN-gamma elispot assayS Janetzki
Swim Across America Laboratory and Departments of Surgery and Medicine, Memorial Sloan Kettering Cancer Center, New York 10021, USA
J Immunol Methods 234:1-12. 2000..Insect cells expressing human HLA molecules provide a standard APC for monitoring CD8(+) T cell responses to tumor and viral peptides during immunotherapy...
In vitro expansion of Ag-specific T cells by HLA-A*0201-transfected K562 cells for immune monitoringJ Yuan
Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA
Cytotherapy 8:498-508. 2006..This HLA-matched APC line can be adapted to other HLA haplotypes, and has advantages for monitoring clinical trials of immunotherapy with limited availability of autologous APC and PBMC from patients...
Induction of pigmentation in mouse fibroblasts by expression of human tyrosinase cDNAB Bouchard
Memorial Sloan Kettering Cancer Center, New York 10021
J Exp Med 169:2029-42. 1989....
Diverse roles of conserved asparagine-linked glycan sites on tyrosinase family glycoproteinsY Xu
The Swim Across America Laboratory, The Weill Graduate School of Medical Sciences of Cornell University, New York, New York 10021, USA
Exp Cell Res 267:115-25. 2001..Different glycan sites on the same tyrosinase family polypeptide can perform distinct functions, and conserved sites on tyrosinase family paralogues can perform different functions...
Coupling and uncoupling of tumor immunity and autoimmunityW B Bowne
Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
J Exp Med 190:1717-22. 1999..e., antibody versus CD8(+) T cell. However, both pathways led to tumor immunity and identical phenotypic manifestations of autoimmunity...
A marker for neoplastic progression of human melanocytes is a cell surface ectopeptidaseM E Morrison
Memorial Sloan Kettering Cancer Center, New York, New York 10021
J Exp Med 177:1135-43. 1993..These findings show that ADAbp is a cell surface ectopeptidase that is tightly regulated during neoplastic transformation of melanocytes...
Development of a xenogeneic DNA vaccine program for canine malignant melanoma at the Animal Medical CenterP J Bergman
Donaldson Atwood Cancer Clinic and Flaherty Comparative Oncology Laboratory, The Animal Medical Center, 510 East 62nd Street, New York, NY 10021, USA
Vaccine 24:4582-5. 2006..These studies provided the impetus for development of a xenogeneic DNA vaccine program in CMM...
Immunization of metastatic breast cancer patients with a fully synthetic globo H conjugate: a phase I trialT Gilewski
Department of Medicine, Memorial Sloan-Kettering Cancer Center, Laboratories of Bio-Organic Chemistry, Sloan-Kettering Institute, 1275 York Avenue, New York, NY 10021, USA
Proc Natl Acad Sci U S A 98:3270-5. 2001..Affinity column purification supported the specificity of IgM antibodies for globo H. On the basis of these data, globo H will constitute one component of a polyvalent vaccine for evaluation in high-risk breast cancer patients...
Reactivity of autologous CD4+ T lymphocytes against human melanoma. Evidence for a shared melanoma antigen presented by HLA-DR15T Takahashi
Immunology Program, Memorial Sloan Kettering Cancer Center, New York, NY 10021
J Immunol 154:772-9. 1995..Thus, by cytotoxicity assays, shared Ags were only recognized on melanoma cells but not on normal melanocytes. In summary, this analysis shows that melanoma cells share an Ag that is presented by HLA-DR15...
The melanoma antigen gp75 is the human homologue of the mouse b (brown) locus gene productS Vijayasaradhi
Immunology Program, Memorial Sloan Kettering Cancer Center, New York, New York 10021
J Exp Med 171:1375-80. 1990..The brown locus determines coat color in the mouse, suggesting that gp75 regulates or influences the type of melanin synthesized...
Assignment of the human TYRP (brown) locus to chromosome region 9p23 by nonradioactive in situ hybridizationV V Murty
Memorial Sloan Kettering Cancer Center, New York, New York 10021
Genomics 13:227-9. 1992..The 9p region has been reported to be nonrandomly altered in human melanoma, suggesting a role for the region near the TYRP locus in melanocyte transformation...
Vaccination with human tyrosinase DNA induces antibody responses in dogs with advanced melanomaJack C F Liao
Flaherty Comparative Oncology Laboratory, Donaldson-Atwood Cancer Clinic, The Animal Medical Center, New York, NY 10021, USA
Cancer Immun 6:8. 2006..Most interestingly, the onset of antibody induction in these three dogs coincides with observed clinical responses and may suggest a means to account for their long-term tumor control and survival...
Langerhans-type dendritic cells genetically modified to express full-length antigen optimally stimulate CTLs in a CD4-dependent mannerJianda Yuan
Laboratory of Cellular Immunobiology, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA
J Immunol 176:2357-65. 2006..LCs, transduced with a retroviral vector encoding full-length Ag, stimulate potent CTLs directed against multiple epitopes in a CD4(+) Th cell-dependent manner...
Autoimmunity and tumor immunity induced by immune responses to mutations in selfManuel E Engelhorn
Swim Across America Laboratory, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, New York 10021, USA
Nat Med 12:198-206. 2006..Thus, presentation of a vast repertoire of antigen variants to the immune system can enhance the generation of adaptive immune responses to self...
Optimization of a self antigen for presentation of multiple epitopes in cancer immunityJose A Guevara-Patino
Swim Across America Laboratory of Tumor Immunology, Memorial Sloan Kettering Cancer Center, New York, New York, USA
J Clin Invest 116:1382-90. 2006....
Estimates of stage-specific survival are altered by changes in the 2002 American Joint Committee on Cancer staging system for melanomaLeah Ben-Porat
Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
Cancer 106:163-71. 2006....
Comparison of two cancer vaccines targeting tyrosinase: plasmid DNA and recombinant alphavirus replicon particlesStacie M Goldberg
Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
Clin Cancer Res 11:8114-21. 2005..The purpose of this study was to compare viral and plasmid DNA in combination vaccination strategies in the context of a tumor antigen...
Antiviral T cell responses: phalanx or multipronged attack?David N Posnett
Department of Medicine, Division of Hematology Oncology, Weill Medical College, Cornell University, New York, NY 10021, USA
J Exp Med 201:1881-4. 2005..Later, in the battle of Marathon described by Herodotus, the Greeks learned the advantages of multipronged attacks, a strategy still used in modern warfare. Is the immune system similar in its approach to combatting pathogens or tumors?..
Agonist anti-GITR antibody enhances vaccine-induced CD8(+) T-cell responses and tumor immunityAdam D Cohen
Swim Across America Laboratory of Tumor Immunology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
Cancer Res 66:4904-12. 2006..Finally, this effect on vaccine-induced CD8(+) T-cell responses was partially independent of CD4(+) T cells (both helper and regulatory), consistent with a direct costimulatory effect on the effector CD8(+) cells themselves...
A T-cell receptor associated with naturally occurring human tumor immunityBianca D Santomasso
Howard Hughes Medical Institute, Laboratory of Molecular Neuro Oncology, The Rockefeller University, New York, NY 10065, USA
Proc Natl Acad Sci U S A 104:19073-8. 2007..Cloned cdr2-specific TCR genes provide a clinically relevant means for immunologic targeting of human gynecologic cancers...
Antibody and CD8+ T cell responses against HER2/neu required for tumor eradication after DNA immunization with a Flt-3 ligand fusion vaccineFrancesca Orlandi
Swim Across America Laboratory, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
Clin Cancer Res 13:6195-203. 2007..HER2/neu is frequently overexpressed in breast cancer. In a mouse model, vaccination with HER2/neu DNA elicits antibodies that confer partial protection against tumor challenge...
Safety and immunogenicity of tyrosinase DNA vaccines in patients with melanomaJedd D Wolchok
Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
Mol Ther 15:2044-50. 2007..Mouse and human TYR DNA vaccines were found safe and induced CD8(+) T-cell responses in 7 of 18 patients. T cells recognizing a native TYR peptide had a phenotype consistent with that of effector memory cells...
Stage-IV melanoma and pulmonary metastases: factors predictive of survivalHeather B Neuman
Gastric and Mixed Tumor Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, 1275 York Ave, Room H1221, New York, New York 10021, USA
Ann Surg Oncol 14:2847-53. 2007..We reviewed a contemporary, single-institution experience to evaluate the natural history of stage-IV melanoma metastatic to the lung and identify factors predictive of survival...
Immunological validation of the EpitOptimizer program for streamlined design of heteroclitic epitopesColin S B Houghton
The Swim Across America Laboratory, Memorial Sloan Kettering Cancer Center, New York, NY 10021, United States
Vaccine 25:5330-42. 2007..These data demonstrate that this approach can serve as the basis of epitope-engineering against cancer and intracellular pathogens...
Immunization of high-risk breast cancer patients with clustered sTn-KLH conjugate plus the immunologic adjuvant QS-21Teresa A Gilewski
Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
Clin Cancer Res 13:2977-85. 2007..To determine the clinical toxicities and antibody response against sTn and tumor cells expressing sTn following immunization of high-risk breast cancer patients with clustered sTn-KLH [sTn(c)-KLH] conjugate plus QS-21...
Phase II study of temozolomide plus pegylated interferon-alpha-2b for metastatic melanomaWen Jen Hwu
Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA
Cancer 106:2445-51. 2006..Therefore, the efficacy and safety of temozolomide in combination with pegylated IFN-alpha-2b in patients with metastatic melanoma without brain metastases was investigated...
Adjuvanticity of plasmid DNA encoding cytokines fused to immunoglobulin Fc domainsCristina R Ferrone
The Swim Across America Laboratory, Memorial Sloan-Kettering Cancer Center, Weill Medical and Graduate Schools of Cornell University, New York, NY 10021, USA
Clin Cancer Res 12:5511-9. 2006....
Phase II study of temozolomide and thalidomide in patients with metastatic melanoma in the brain: high rate of thromboembolic events (CALGB 500102)Susan E Krown
Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York, USA
Cancer 107:1883-90. 2006..These observations provide little support for the use of this combination for melanoma brain metastases unless safe and effective methods to prevent thrombosis are developed...
DNA immunization against tissue-restricted antigens enhances tumor immunity after allogeneic hemopoietic stem cell transplantationMiguel Angel Perales
Swim Across America Laboratory of Tumor Immunology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
J Immunol 177:4159-67. 2006..These results demonstrate that DNA immunization against tissue-restricted Ags after allogeneic T cell-depleted HSCT can induce potent antitumor effects without causing GVHD...
MelanomaAlan N Houghton
J Natl Compr Canc Netw 4:666-84. 2006
Glucocorticoid-induced TNF receptor family related gene activation overcomes tolerance/ignorance to melanoma differentiation antigens and enhances antitumor immunityTeresa Ramirez-Montagut
Department of Medicine and Immunology Program, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
J Immunol 176:6434-42. 2006..Thus, we conclude that overall, GITR stimulation overcomes self-tolerance/ignorance and enhances T cell-mediated antitumor activity with minimal autoimmunity...
Mechanisms of immunization against cancer using chimeric antigensManuel E Engelhorn
The Swim Across America Laboratory, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
Mol Ther 16:773-81. 2008..Therefore large fusion vector panels such as those presented here can provide information to promote the successful advancement of gene-based vaccines...
Temozolomide plus thalidomide in patients with brain metastases from melanoma: a phase II studyWen Jen Hwu
Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA
Cancer 103:2590-7. 2005..The current Phase II study examined the efficacy and safety of this combination in chemotherapy-naive patients with brain metastases...
Immunity to melanoma: unraveling the relation of tumor immunity and autoimmunityTeresa Ramirez-Montagut
Memorial Sloan-Kettering Cancer Center and the Weill Graduate School of Medical Sciences of Cornell University, 1275 York Avenue, New York, NY 10021, USA
Oncogene 22:3180-7. 2003..Vitiligo (autoimmune hypopigmentation) can be mediated by T cells, FcgammaR+macrophages and/or complement...
Induction of autoantibodies against tyrosinase-related proteins following DNA vaccination: unexpected reactivity to a protein paralogueRoopa Srinivasan
Swim Across America Laboratory and Department of Medicine, Memorial Sloan-Kettering Cancer Center and Weill Medical College and Graduate School of Cornell University, New York, NY 10021, USA
Cancer Immun 2:8. 2002..This represents an example of intermolecular determinant recognition, but is not simply due to epitope spreading since antibodies against the antigen targeted by DNA vaccination are not typically detected...
A single heteroclitic epitope determines cancer immunity after xenogeneic DNA immunization against a tumor differentiation antigenJason S Gold
Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA
J Immunol 170:5188-94. 2003....
Classification of clear-cell sarcoma as a subtype of melanoma by genomic profilingNeil H Segal
Memorial Sloan Kettering Cancer Center, 1275 York Ave, New York, NY 10021, USA
J Clin Oncol 21:1775-81. 2003..CCS/MSP also has typical melanoma features, including immunoreactivity for S100 and HMB45, pigmentation, MITF-M expression, and a propensity for regional lymph node metastases...
Long-term survival of dogs with advanced malignant melanoma after DNA vaccination with xenogeneic human tyrosinase: a phase I trialPhilip J Bergman
Donaldson Atwood Cancer Clinic and Flaherty Comparative Oncology Laboratory, The E and M Bobst Hospital of the Animal Medical Center, New York, New York 10021, USA
Clin Cancer Res 9:1284-90. 2003..These studies provided the rationale for a trial of xenogeneic DNA vaccination in CMM using the human tyrosinase gene...
The role of lipopolysaccharide in T-cell responses following DNA vaccinationWilliam G Hawkins
Swim Across America Laboratory, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA
Vaccine 21:1548-53. 2003..CD8(+) T-cell responses were readily induced in TLR4-deficient mice immunized with DNA depleted of LPS. LPS in DNA vaccines is not required for CD8(+) T-cell responses...
Multiple pathways to tumor immunity and concomitant autoimmunityMary Jo Turk
1Weill Graduate School of Medical Sciences of Cornell University, New York, USA
Immunol Rev 188:122-35. 2002..Autoimmunity uses similar mechanisms as tumor immunity, but tumor immunity and autoimmunity can uncouple. These studies open up strategies for active immunization against cancer...
Redundant and alternative roles for activating Fc receptors and complement in an antibody-dependent model of autoimmune vitiligoJiri Trcka
The Swim Across America Laboratory, Memorial Sloan Kettering Cancer Center and Weill Graduate School of Cornell University, New York, NY 10021, USA
Immunity 16:861-8. 2002..Thus, either complement or macrophages expressing activating Fc gamma R can independently and alternatively mediate disease in a model of autoimmune vitiligo...
Temozolomide plus thalidomide in patients with advanced melanoma: results of a dose-finding trialWen Jen Hwu
Departments of Medicine, Epidemiology and Biostatistics, and Radiology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
J Clin Oncol 20:2610-5. 2002..To establish a safe and tolerated regimen of an oral cytotoxic agent, temozolomide, and a cytostatic agent, thalidomide, in patients with unresectable stage III or IV malignant melanoma...
T-cell responses against tyrosinase 368-376(370D) peptide in HLA*A0201+ melanoma patients: randomized trial comparing incomplete Freund's adjuvant, granulocyte macrophage colony-stimulating factor, and QS-21 as immunological adjuvantsSusanne G Schaed
Swim Across America Laboratory of Tumor Immunology, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA
Clin Cancer Res 8:967-72. 2002....
GM-CSF DNA induces specific patterns of cytokines and chemokines in the skin: implications for DNA vaccinesMiguel Angel Perales
The Swim Across America Laboratory, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
Cytokines Cell Mol Ther 7:125-33. 2002..These results have implications for understanding early events in the immune response to DNA vaccines, and provide a basis for development of new approaches to cancer vaccines, including the use of cytokine genes as adjuvants...
Xenogeneic DNA immunization in melanoma models for minimal residual diseaseWilliam G Hawkins
Swim Across America Laboratory, Departments of Surgery and Medicine, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, New York 10021, USA
J Surg Res 102:137-43. 2002....
Induction of autoantibodies to syngeneic prostate-specific membrane antigen by xenogeneic vaccinationPolly D Gregor
Genitourinary Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
Int J Cancer 116:415-21. 2005..These results establish the basis for clinical trials to test PSMA DNA vaccines in patients with solid tumors that either express PSMA directly or that depend on normal endothelial cells expressing PSMA for their continued growth...
CD8+ T-cell-dependent immunity following xenogeneic DNA immunization against CD20 in a tumor challenge model of B-cell lymphomaMaria Lia Palomba
Department of Medicine and Immunology Program, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
Clin Cancer Res 11:370-9. 2005..These results show that active immunization with xenogeneic DNA vaccines can induce CD8+ T cell-dependent immunity against CD20...
Concomitant tumor immunity to a poorly immunogenic melanoma is prevented by regulatory T cellsMary Jo Turk
The Swim Across America Laboratory of Tumor Immunology, Memorial Sloan-Kettering Cancer Center, 1275 York Ave, New York, NY 10021, USA
J Exp Med 200:771-82. 2004..These results show that regulatory T cells are the major regulators of concomitant tumor immunity against this weakly immunogenic tumor...
GITR activation induces an opposite effect on alloreactive CD4(+) and CD8(+) T cells in graft-versus-host diseaseStephanie J Muriglan
Department of Medicine and Immunology, Memorial Sloan Kettering Cancer Center, Kettering 425, Mailbox 111, 1275 York Ave, New York, NY 10021, USA
J Exp Med 200:149-57. 2004..Our findings indicate that GITR has opposite effects on the regulation of alloreactive CD4(+) and CD8(+) T cells...
FAPalpha, a surface peptidase expressed during wound healing, is a tumor suppressorTeresa Ramirez-Montagut
Swim Across America Laboratory, Memorial Sloan Kettering Cancer Center and Weill Graduate School of Medical Sciences of Cornell University, 1275 York Avenue, New York, NY 10021, USA
Oncogene 23:5435-46. 2004..These results show that expression of FAP is a tumor suppressor that abrogates tumorigenicity through regulation of cell growth and survival...
CTLA-4 blockade in combination with xenogeneic DNA vaccines enhances T-cell responses, tumor immunity and autoimmunity to self antigens in animal and cellular model systemsPolly D Gregor
Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA
Vaccine 22:1700-8. 2004..Based on these pre-clinical studies, we suggest that anti-CTLA-4 should be tested with xenogeneic DNA vaccines against cancer and that special attention should be given to sequence and schedule of administration...
Role for dipeptidyl peptidase IV in tumor suppression of human non small cell lung carcinoma cellsUmadevi V Wesley
Swim Across America Laboratory, Memorial Sloan Kettering Cancer Center, New York, NY, USA
Int J Cancer 109:855-66. 2004..Thus, DPPIV functions as a tumor suppressor, and its downregulation may contribute to the loss of growth control in NSCLC cells...
Immunity to cancer through immune recognition of altered self: studies with melanomaJose A Guevara-Patino
Memorial Sloan Kettering Cancer Center and the Weill Graduate School of Medical Sciences and Medical School of Cornell University, 1275 York Avenue, New York, NY 10021, USA
Adv Cancer Res 90:157-77. 2003..Studies examining the molecular basis for immunogenicity of conserved paralogues are facilitating the development of new strategies to rationally design vaccines that trigger adaptive immune responses to cancer...
Phase II study of temozolomide plus thalidomide for the treatment of metastatic melanomaWen Jen Hwu
Memorial Sloan Kettering Cancer Center, 1275 York Ave, New York, NY 10021, USA
J Clin Oncol 21:3351-6. 2003..To further investigate the efficacy and safety of temozolomide plus thalidomide in patients with metastatic melanoma without brain metastases...
Classification and subtype prediction of adult soft tissue sarcoma by functional genomicsNeil H Segal
Swim Across America Laboratory, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York and Columbia Genome Center, Columbia University, New York, New York 10021, USA
Am J Pathol 163:691-700. 2003..In conclusion, we showed gene expression profiling to be useful in classification and diagnosis, providing insights into pathogenesis and pointing to potential new therapeutic targets of soft tissue sarcoma...
Strategies to overcome immune ignorance and toleranceMiguel Angel Perales
Memorial Sloan Kettering Cancer Center and Weill Medical School and Graduate School of Cornell University, New York, NY 10021, USA
Semin Cancer Biol 12:63-71. 2002..Crucial to these approaches is the discovery and understanding of the molecular identity of antigens and the mechanisms involved in tumor immunity. In this review, strategies to overcome immune ignorance and tolerance are discussed...
Analysis of BRAF and N-RAS mutations in metastatic melanoma tissuesAlexis Gorden
Ronald O. Perelman Department of Dermatology, New York University School of Medicine, New York, New York 10016, USA
Cancer Res 63:3955-7. 2003..Our data show that BRAF mutation is common in melanoma metastases, regardless of their site, that mutations include both exons 11 and 15, and suggest that anti-RAS/RAF strategies may be effective in metastatic melanoma patients...
Research Grants
- IMMUNIZATION AGAINST MELANOMA DIFFERENTIATION ANTIGENSJedd D Wolchok; Fiscal Year: 2010..The overall goal of this grant is to develop more effective strategies to use the immune system to recognize specific targets present on melanoma cells. ..
- IMMUNIZATION AGAINST MELANOMA DIFFERENTIATION ANTIGENSAlan Houghton; Fiscal Year: 2009..In aim 4, we will continue to create more relevant mouse models of melanoma that develop endogenous invasive melanomas to study tumor immunity against differentiation and mutant antigens. ..
- Targeted antigen receptor treatment of cancerAlan Houghton; Fiscal Year: 2007....
- IMMUNIZATION AGAINST MELANOMA DIFFERENTIATION ANTIGENSAlan Houghton; Fiscal Year: 2004..and 3) Develop mouse models that develop endogenous invasive melanomas and study immunity against differentiation antigens at different steps in tumor progression. ..
- ACTIVE IMMUNOTHERAPY OF MELANOMAAlan Houghton; Fiscal Year: 1993..These studies will give insights into immune recognition of differentiation and tumor-specific antigens expressed by cancer cells and provide strategies for construction of cancer vaccines...
- IMMUNIZATION AGAINST MELANOMA DIFFERENTIATION ANTIGENSALAN N contact HOUGHTON; Fiscal Year: 2011..The overall goal of this grant is to develop more effective strategies to use the immune system to recognize specific targets present on melanoma cells. ..
